Application of Licorice Preparation for Patients with Bronchial Asthma and Assessment of Clinical and Immunological Parameters

obstruction hemoptysis damage to the bronchial mucosa dyspnea

Authors

  • Yuldasheva S. X. Assistant, Tashkent Medical Academy, Urgench branch. 28 Al-Khorezmiy Street, Urgench, Republic of Uzbekistan
March 27, 2025

Downloads

Bronchial asthma is an atopic disease characterized by chronic inflammation and hyperreactivity of the respiratory tract, and is a global medical problem. The prevalence of asthma has been increasing steadily since the end of the last century in countries with a Western lifestyle, and is also increasing in developing countries. The number of patients is estimated at 300 million people. Despite the revolutionary changes that have taken place in the treatment of bronchial asthma over the past 40 years (the transition from oral use of non-selective adrenergic bronchodilators to new symptomatic and preventive therapies using convenient inhalers), the situation regarding the control of this disease remains tense. Recently, the results of international epidemiological studies have been published, according to which disease control has been registered in only 5 to 30% of patients [8].

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.